FOLLOW US
For Professionals » Research Updates » Graves' Disease

Graves' Disease Research Updates

For Medical Professionals

FDA Approves First Drug for Thyroid Eye Disease
The first drug specifically for the treatment of thyroid eye disease has been approved by the FDA.
Selection of Long-term Antithyroid Treatment Debated
Thyroidectomy by High Volume Surgeon Offers Best Outcomes for Grave's Disease
Radioactive Iodine Considered Optimal For Graves' Disease
Prevalence of Grave’s Disease Varies Widely by Race/Ethnicity
Non-Hispanic blacks have a nearly 3-fold higher prevalence of thyrotoxicosis than non-Hispanic whites, according to analysis of data from National Health and Nutritional Examination Surveys (NHANES) reported in the June issue of Thyroid.
close X
SHOW MAIN MENU
SHOW SUB MENU